MARK MILLER: Open Payments
NPI 1184676041 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 11 payments from 9 companies in 2025. Trend: 2023 $1,094 · 2024 $608 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $39 |
| Radius Health, Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Antares Pharma, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: REXULTI, Wegovy, Tymlos, Ohtuvayre, VYNDAMAX, Cologuard Collection Kit, XYOSTED, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
